Export

Renovaro Biosciences Denmark ApS

Financial information

The information source is the annual report of the company with VAT No DK26027322

* Closing information (×1000) DKK

Fiscal year 202306 202206
Turnover: 0 0
Earnings before taxes: -2,163 Revenue Up -10,264 Revenue Down
Total assets: 1,467 Revenue Up 1,267 Revenue Down
Current assets: 1,233 Revenue Up 952 Revenue Down
Current liabilities: 144 Revenue Down 363 Revenue Down
Equity capital: -79,908 Revenue Down -77,745 Revenue Down
Share capital: 4,003 4,003
Number of employees: 1 1

Financial ratios

Solvency: -5.447.0% Revenue Up -6.136.1% Revenue Down
Turnover per employee: 0 0
Profitability: -Infinity% -Infinity%
Return on equity (ROE): 2.7% Revenue Down 13.2% Revenue Up
Current ratio: 856.2% Revenue Up 262.3% Revenue Up
Fiscal year 202306
Turnover: 0
Earnings before taxes: -2,163
Total assets: 1,467
Current assets: 1,233
Current liabilities: 144
Equity capital: -79,908
Share capital: 4,003
Number of employees: 1

Financial ratios

Solvency: -5.447.0%
Turnover per employee: 0
Profitability: -Infinity%
Return on equity (ROE): 2.7%
Current ratio: 856.2%